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Abstract
Background: Majority of patients with solitary fibrous tumours of the pleura (SFTP) are asymptomatic. Acute
presentation with symptoms resulting from mass effect due to rapid expansion of tumour size has not been
reported before.
Case presentation: This report chronicles the case of a giant SFTP in a 76-year-old lady who presented with acute
onset of haemoptysis, left-sided pleuritic chest pain and hoarseness of voice. Her chest radiograph showed a large
left upper hemithorax mass with an ipsilateral effusion. Computed tomography (CT) scan of the thorax confirmed
the presence of a pleural-based mass lesion in the left apex measuring 9.7 cm with close apposition to the aortic arch.
The mass demonstrated neovascularization and there was also presence of a moderate-sized heterogeneous-appearing
left pleural effusion. Thoracocentesis yielded deeply haemoserous pleural fluid with a pleural aspirate hematocrit closely
approaching that of peripheral blood hematocrit and alongside a 2 unit decrease in haemoglobin, was indicative of a
haemothorax. Repeat CT 10 days from initial presentation showed reduction in size of the left apical mass as well as
resolution of the left effusion. This was consistent with the occurrence of an intra-tumoural bleed resulting in rapid
increase in the size of the SFTP, causing rupture of superficial blood vessels on the tumour surface (haemothorax) and
consequential compression of the lung parenchyma (haemoptysis) and left recurrent laryngeal nerve (hoarseness of
voice). The patient eventually underwent an uneventful surgical resection.
Conclusion: A benign SFTP can present acutely with compressive symptoms as a result of spontaneous intra-tumoural
bleed causing sudden increase in its size. It is important to allow temporal regression of these acute changes before
deciding on surgical resectability.
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Background
Solitary fibrous tumours of the pleura (SFTP) are un-
common tumours of mesenchymal origin. Majority of
patients with SFTP are asymptomatic. Haemoptysis and
spontaneous haemothorax as initial manifestations are un-
common. A definitive diagnosis requires histopathological/
immunohistochemical examination of tumour specimens
[1], with the best yield from resected tumours. Complete en
bloc resection of the tumour is the mainstay of therapy for
SFTP, regardless of it being benign or malignant.
Case presentation
A 76-year-old previously well lady presented to a hospital
while on overseas vacation with acute onset of haemoptysis,
left-sided pleuritic chest pain and hoarseness of voice that
lasted three days. This was associated with weight loss of
7 kg over past two years. She was a lifelong non-smoker,
and had no reported history of chest trauma before the
onset of her symptoms. She subsequently returned to our
centre one week later for further evaluation. Physical
examination revealed a thin lady (BMI 13.4 kg/m2) who
was afebrile with normal blood pressure and pulse rate.
Her oxyhaemoglobin saturation on pulse oximetry was nor-
mal at 95 % on room air. She had no clubbing or cervical
lymphadenopathy. Examination of the lungs revealed stony
dullness to percussion in the left lung base with decreased
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breath sounds throughout the left chest. A radiograph
(Fig. 1) performed showed a large, left upper hemithorax
mass with an ipsilateral moderate sized left pleural effusion.
A computed tomography (CT) scan of the thorax (Fig. 2)
confirmed the presence of a large pleural-based mass in the
left apex measuring 9.7 × 8.4 × 4.5 cm, with close ap-
position to the aortic arch, resulting in the collapse of
the adjacent lung parenchyma. This mass also demon-
strated neovascularization. There was presence of a left
pleural effusion containing hyper-dense elements, which
suggested the presence of blood or tumour within the
pleural space. Laboratory investigation results showed a
significant for a drop in haemoglobin of two units from
her baseline (12.4→ 10.5 g/dl).
Bedside thoracic ultrasonography revealed a left effusion
with heterogeneous appearance. Diagnostic thoracocentesis
yielded deeply haemoserous pleural aspirate which was
exudative by Light’s criteria [2]. Pleural fluid haematocrit
(30.8 %) closely approached that of peripheral blood haem-
atocrit (31.2 %), hence indicative of haemothorax. Pleural
fluid cytology was non-diagnostic with rare, atypical cells
seen. She further underwent a transthoracic needle Trucut
biopsy of the left apical mass, and histopathological features
were suggestive of a spindle cell neoplasm (bcl-2 positive,
CD34 weakly positive, mesothelial markers CK 5/6, WT1
and calretinin negative) with a mitotic index Ki67 < 5 %.
A subsequent nasoendoscopy also confirmed the pres-
ence of left vocal cord palsy, likely caused by the huge mass
effect on the intrathoracic component of the left recurrent
laryngeal nerve.
The patient’s pre-operative pulmonary function test
was normal (FEV1 1.20 L; 105 % predicted and FVC
1.42 L; 81 % predicted) with a moderately reduced
diffusion capacity for carbon monoxide (DLCO) corrected
for haemoglobin (2.74 mM/min/kPa; 52 % predicted). Her
transfer coefficient of the lung (KCO i.e., DLCO/VA;
VA = alvelolar volume) was normal, at 80 % predicted.
At a multidisciplinary chest tumour meeting, thoracic
surgeons expressed concerns about the resectability of
the mass. This was because of its close apposition to the
mediastinum, as well as the possibility of a malignant
tumour in the left pleural space which might have
invaded the left recurrent laryngeal nerve in an elderly
patient with weight loss, and a moderately impaired
diffusion capacity which would have deemed her high
risk for pneumonectomy if surgically necessary. Based
on the opinions of our radiologists and thoracic surgeons
and the clincoradiological evidence of intratumoral and
pleural haemorrhage of a histological proven SFTP (with
no malignant features) in an otherwise well lady, the
primary care physicians (the authors of this manuscript)
decided to repeat a CT scan about 2 weeks later to
reassess the extent of the tumor with regards to surgical
resectability. An interval CT scan (10 days apart from the
Trucut biopsy; Figs. 3 and 4) showed significant decrease
in the size of the mass, and a complete resolution of the
pleural effusion. The patient eventually underwent left
posterolateral thoracotomy, with excision of the pleural
tumour. The post-operative recovery was uneventful, and
a CT scan showed re-expansion of the left upper lobe,
after resection of the SFTP.
Approximately 1,500 cases of SFTP have been reported
in the literature [1, 3]. The majority of patients are asymp-
tomatic at presentation despite a large tumour size. Com-
mon symptoms when present include chest pain, cough
and dyspnoea [4, 9] (Table 1). Haemoptysis is a rare mani-
festation, accounting for 2 to 4 % of patients with SFTP in
previous reports [4, 5] and appears to be more common
in malignant variants [5, 6]. Thus it was unusual for our
Fig. 1 Chest radiograph showed a huge mass in the upper left
hemithorax and an ipsilateral moderate-sized pleural effusion
Fig. 2 Computed tomography scan of the thorax revealed a large
heterogenous mass in the left upper hemithorax with neovascularization
(black arrows)
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patient to present with haemoptysis, as her eventual histo-
pathology from the resected tumour did not demonstrate
any evidence of malignant transformation. Spontaneous
haemothorax associated with SFTP is an even rarer occur-
rence, with only a handful anecdotal reports in the litera-
ture [6–8]. Hoarseness of voice related to SFTP has never
been reported.
Our patient’s presentation of sudden onset of haem-
optysis, chest pain and hoarseness of voice can be ex-
plained by an acute intra-tumoural bleed which caused
a rapid increase in size of the SFTP with consequential
compressive symptoms. The patient’s haemoptysis
could possibly be explained by the huge tumour that
caused compression of the adjacent lung parenchyma
or airways with distal atelectasis and inflammation [9].
In addition, we postulate that there could be localized
pulmonary infarction resulting from the acute mass
effect on the pulmonary circulation, which could also
lead to the manifestation of hemoptysis. Lung parenchymal
inflammation contributed to the patient’s pleurisy, which
could also be due to presence of blood in the pleural space.
The spontaneous rupture of superficial blood vessels on the
surface of the tumour and/or the shear forces from the
rapid tumour expansion (due to intra-tumoural bleed) led
to haemothorax. The other compressive symptom was her
hoarseness of voice, which was possibly a result of acute
pressure exerted by the tumour on the left recurrent
laryngeal nerve. To our knowledge, this is the first report
of acute compressive symptoms caused by intra-tumoural
bleed, resulting in rapid expansion in the size of a SFTP.
The above postulations on intra-tumoral bleed and haemo-
thorax are supported by an acute drop in her haemoglobin,
pleural aspirate haematocrit, and radiological evidence of
significant reduction of the left apical mass which demon-
strated neovascularisation, as well as the resolution of the
left pleural effusion (Figs. 3 and 4) within 10 days. This is
likely explained by the natural history of blood resorption
within the tumour and pleural space.
Diagnosis of SFTP is challenging due to the lack of
specific clinical symptoms and radiographic appearances,
as illustrated by the patient in our report who had a rather
unique clinical presentation. Differential diagnoses often
include bronchogenic carcinoma, malignant mesothelioma
and pleural sarcoma. Often, a transthoracic needle core
biopsy would be required to differentiate SFTP from other
diagnoses. However, the diagnostic yield of needle sampling
was variable (ranging from 17 to 45 %) [10–12]. At best, it
provides a moderate yield for a definitive pre-operative
diagnosis of SFTP. When clinicoradiological features appear
to be classically SFTP, most authors advise against a needle
biopsy, since it would not alter the eventual management
outcome i.e., surgical resection [1, 13].
The mainstay of treatment for SFTP is a complete en
bloc resection of the mass [1, 10, 12]. Pedunculated tu-
mours can be safely resected with wedge resection of the
adjacent lung. Large sessile tumours can pose a challenge
Fig. 3 Comparison of the images at the level of the carina during biopsy (a) and 10 days later (b) showed significant decrease in the size of
the left apical mass
Fig. 4 Comparison of the images at a lower level bifurcation of the pulmonary trunk during biopsy (a) and 10 days later (b) showed complete
resolution of the left pleural effusion that gravitated below the mass
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during surgery, and may occasionally require a lobectomy
or pneumonectomy in order to achieve complete resection
[1]. In a series [11] describing 60 patients with surgical
resection done for SFTP, six (10 %) required either lobec-
tomy or pneumonectomy. These features may not be
readily apparent in pre-operative radiological imaging
studies, and thus there may be no way to predict the extent
of lung resection prior to surgery.
There is a paucity of literature on the pre-operative
pulmonary assessment of patients requiring surgery for
SFTP and large pleural tumours, as existing guidelines
[14] only describe pre-operative pulmonary assessment
for patients requiring lung resection. Had our patient
required a pneumonectomy in the worst-case scenario,
her predicted post-operative (PPO) FEV1 and DLCO
would have been 53 and 26 % predicted. The latter value
would have rendered her an unacceptable surgical risk
[14, 15]. According to the American College of Chest
Physician guidelines [14], patients with PPO FEV1 or
DLCO < 60 % predicted have to undergo further physio-
logical assessment with a cardiopulmonary exercise test
(CPET) before determining surgical fitness. However, it
was noted that her transfer coefficient of the lung (KCO
i.e., DLCO/VA; VA = alveolar volume) was normal at
80 % predicted. Her large SFTP had resulted in extra-
pulmonary reduction in lung inflation, causing a reduced
VA. This was largely responsible for the reduction in
DLCO [16]. Hence, further pre-operative pulmonary
assessment with lung perfusion scan and cardiopulmonary
exercise testing for VO2 max were not required. The
patient subsequently underwent excision of the pleural
tumour with minimal lung resection, and had an uneventful
post-operative recovery. The risk of recurrence after
complete surgical resection can range from <2 % in
benign SFTP to 63 % in malignant forms [1].
This case illustrates that KCO can potentially be useful
in pre-operative assessment of patients with giant SFTP
that results in reduced DLCO, although evidence from
larger scale studies would be required to support this
hypothesis. It would be very unfortunate had the patient
been denied surgery, had she been deemed a high-risk
candidate based on her decreased DLCO alone.
Conclusion
This report showcases a rare manifestation of a benign
SFTP with an acute increase in size due to spontaneous
intra-tumoural bleeding, which in turn led to haemothorax
and compressive symptoms. The simultaneous occurrence
of these factors resulted in the earlier presentation of an
otherwise slow-growing tumour. It is important to allow
temporal regression of these acute changes before deciding
on surgical resectability. This case also highlights the
potential usefulness of KCO in determining a patient’s
pre-operative risk for large pleural tumours that may
require lung resection. If pre-operative risk was deter-
mined by reduced DLCO alone, patients who need
surgery would be denied it.
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